BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/26/0.1/21.06.24 Stock

Warrant

E8KNB

NLBNPFR1WP64

Market Closed - Euronext Paris 12:30:02 2024-05-20 pm EDT
0.015 EUR 0.00% Intraday chart for BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/26/0.1/21.06.24
Current month-88.89%
1 month-88.89%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 0.015 0.00%
24-05-17 0.015 0.00%
24-05-16 0.015 0.00%
24-05-15 0.015 -25.00%
24-05-14 0.02 0.00%

Real-time Euronext Paris

Last update May 20, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
E8KNB
ISINNLBNPFR1WP64
Date issued 2023-12-05
Strike 26 $
Maturity 2024-06-21 (32 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.225
Lowest since issue 0.015
Delta-0.13x
Omega 21.28
Premium9.71x
Gearing169.87x
Moneyness 0.9088
Difference Strike -2.53 $
Difference Strike %-9.73%
Spread 0.029
Spread %96.67%
Theoretical value 0.0155
Implied Volatility 30.70 %
Total Loss Probability 85.50 %
Intrinsic value 0.000000
Present value 0.0155
Break even 25.83 €
Theta-0.01x
Vega0x
Rho-0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.64 USD
Average target price
31.94 USD
Spread / Average Target
+11.52%
Consensus
  1. Stock Market
  2. Warrants
  3. E8KNB Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW